(Q37733546)

22 August 2017

1 reference

title

Recent patents in the discovery of small molecule inhibitors of JAK3. (English)

1 reference

22 August 2017

0 references

Lawrence J Wilson

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Expert Opinion on Therapeutic Patents

22 August 2017

published in

1 reference

22 August 2017

volume

20

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

609-623

1 reference

Jaks and Stats in signaling by the cytokine receptor superfamily

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Therapeutic targeting of Janus kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Is JAK3 a new drug target for immunomodulation-based therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Interleukin 4 signals through two related pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

The JAK-STAT signaling pathway: input and output integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003709767

10.1517/13543771003709767

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference